Hypothyroidism in thyroid carcinoma follow-up: orlistat may inhibit the absorption of thyroxine.
Madhava
K
K
Hartley
A
A
D002291:Carcinoma, Papillary / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000188:drug therapy; D007783:Lactones / Q000627:therapeutic use*; D008049:Lipase / Q000037:antagonists & inhibitors; D008875:Middle Aged; D000077403:Orlistat; D013964:Thyroid Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013974:Thyroxine / Q000009:adverse effects / Q000097:blood
D004791:Enzyme Inhibitors; D007783:Lactones; D000077403:Orlistat; D008049:Lipase; D013974:Thyroxine